This inventor holds 3 USPTO granted patents and 10 published patent applications. Top assignee: Incyte Corporation. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Rocco Policarpo: Innovator in KRAS Inhibition
Introduction
Rocco Policarpo is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit KRAS activity. With a total of 3 patents to his name, Policarpo's work is pivotal in the fight against diseases associated with KRAS, such as cancer.
Latest Patents
Policarpo's latest patents include innovative compounds designed to inhibit KRAS activity. One of his patents focuses on tricyclic compounds that serve as inhibitors of KRAS. These compounds are disclosed in a specific formula and are intended for use in treating, preventing, or ameliorating diseases linked to KRAS activity. Another patent involves quinoline compounds, which also act as inhibitors of KRAS, providing similar therapeutic benefits.
Career Highlights
Rocco Policarpo is currently associated with Incyte Corporation, where he continues to advance his research and development efforts. His work is characterized by a commitment to creating effective pharmaceutical solutions that address critical health challenges.
Collaborations
Policarpo collaborates with esteemed colleagues, including Xiaozhao Wang and Alexander Sokolsky. Their combined expertise enhances the innovative potential of their research endeavors.
Conclusion
Rocco Policarpo's contributions to the field of pharmaceutical sciences, particularly in KRAS inhibition, underscore his role as a leading inventor. His patents reflect a dedication to improving treatment options for serious health conditions.